Literature DB >> 31238711

Protein Cytokines, Cytokine Gene Polymorphisms, and Potential Acute Coronary Syndrome Symptoms.

Sahereh Mirzaei1, Larisa Burke1, Anne G Rosenfeld2, Susan Dunn1, Jennifer R Dungan3, Katherine Maki1, Holli A DeVon1.   

Abstract

The purpose of this study was to determine whether relationships exist among protein cytokines, cytokine gene polymorphisms, and symptoms of potential acute coronary syndrome (ACS). Participants included 438 patients presenting to the emergency department (ED) whose symptoms triggered a cardiac evaluation (206 ruled in and 232 ruled out for ACS). Presence or absence of 13 symptoms was recorded upon arrival. Levels of tumor necrosis factor α (TNF-α), interleukin (IL)-6, and IL-18 were measured for all patients. A pilot analysis of 85 patients (ACS = 49; non-ACS = 36) genotyped eight single-nucleotide polymorphisms (SNPs; four TNF and four IL6 SNPs). Logistic regression models were tested to determine whether cytokines or SNPs predicted symptoms. Increased levels of TNF-α and IL-6 were associated with a decreased likelihood of chest discomfort for all patients. Increased levels of IL-6 were associated with a lower likelihood of chest discomfort and chest pressure for ACS patients, and an increased likelihood of shoulder and upper back pain for non-ACS patients. Elevated IL-18 was associated with an increased likelihood of sweating in patients with ACS. Of the four TNF SNPs, three were associated with shortness of breath, lightheadedness, unusual fatigue, and arm pain. In all, protein cytokines and TNF polymorphisms were associated with 11 of 13 symptoms assessed. Future studies are needed to determine the predictive ability of cytokines and related SNPs for a diagnosis of ACS or to determine whether biomarkers can identify patients with specific symptom clusters.

Entities:  

Keywords:  acute coronary syndrome; cytokines; inflammation; single-nucleotide polymorphisms; symptoms

Mesh:

Substances:

Year:  2019        PMID: 31238711      PMCID: PMC6854427          DOI: 10.1177/1099800419857819

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  68 in total

Review 1.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

2.  Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes.

Authors:  Judd E Hollander; Andra L Blomkalns; Gerard X Brogan; Deborah B Diercks; John M Field; J Lee Garvey; W Brian Gibler; Timothy D Henry; James W Hoekstra; Brian R Holroyd; Yuling Hong; J Douglas Kirk; Brian J O'Neil; Raymond E Jackson; Tom Aufderheide; Andra L Blomkalns; Gerard X Brogan; James Christenson; Sean Collins; Deborah B Diercks; Francis M Fesmire; J Lee Garvey; Gary B Green; Christopher J Lindsell; W Frank Peacock; Charles V Pollack; Robert Zalenski
Journal:  Ann Emerg Med       Date:  2004-12       Impact factor: 5.721

Review 3.  Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?

Authors:  Waldiceu A Verri; Thiago M Cunha; Carlos A Parada; Stephen Poole; Fernando Q Cunha; Sérgio H Ferreira
Journal:  Pharmacol Ther       Date:  2006-05-30       Impact factor: 12.310

4.  Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels.

Authors:  Meian He; Marilyn C Cornelis; Peter Kraft; Rob M van Dam; Qi Sun; Cathy C Laurie; Daniel B Mirel; Daniel I Chasman; Paul M Ridker; David J Hunter; Frank B Hu; Lu Qi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

5.  Role of IL-18 in overt pain-like behaviour in mice.

Authors:  Waldiceu A Verri; Thiago M Cunha; Danilo A Magro; Andressa C Domingues; Silvio M Vieira; Guilherme R Souza; Foo Y Liew; Sérgio H Ferreira; Fernando Q Cunha
Journal:  Eur J Pharmacol       Date:  2008-04-09       Impact factor: 4.432

6.  Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012.

Authors:  Dragana Radovanovic; Burkhardt Seifert; Philip Urban; Franz R Eberli; Hans Rickli; Osmund Bertel; Milo A Puhan; Paul Erne
Journal:  Heart       Date:  2013-11-01       Impact factor: 5.994

Review 7.  Role of TNF-alpha during central sensitization in preclinical studies.

Authors:  Pablo Andrade; Veerle Visser-Vandewalle; Carolin Hoffmann; Harry W M Steinbusch; Marc A Daemen; Govert Hoogland
Journal:  Neurol Sci       Date:  2011-05-11       Impact factor: 3.307

8.  Influence of cytokine gene polymorphisms on proinflammatory/anti-inflammatory cytokine imbalance in premature coronary artery disease.

Authors:  Wafa Munir Ansari; Steve E Humphries; Abdul Khaliq Naveed; Omer Jamshed Khan; Dilshad Ahmed Khan
Journal:  Postgrad Med J       Date:  2016-08-24       Impact factor: 2.401

9.  Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

Authors:  S J Sukoff Rizzo; S J Neal; Z A Hughes; M Beyna; S Rosenzweig-Lipson; S J Moss; N J Brandon
Journal:  Transl Psychiatry       Date:  2012-12-04       Impact factor: 6.222

10.  Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases.

Authors:  Kathryn T Weber; D Olivier Alipui; Cristina P Sison; Ona Bloom; Shaheda Quraishi; M Chris Overby; Mitchell Levine; Nadeen O Chahine
Journal:  Arthritis Res Ther       Date:  2016-01-07       Impact factor: 5.156

View more
  1 in total

Review 1.  Meta-analysis of the relationship between interleukin-6 levels and the prognosis and severity of acute coronary syndrome.

Authors:  Chongzhe Yang; Zhiyong Deng; Jie Li; Zhilei Ren; Feng Liu
Journal:  Clinics (Sao Paulo)       Date:  2021-07-05       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.